These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9632910)

  • 1. Surfactant inactivation and surfactant therapy in acute respiratory distress syndrome (ARDS).
    Robertson B
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):64-9. PubMed ID: 9632910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of surfactant in the pathophysiology of the acute respiratory distress syndrome (ARDS).
    Hartog A; Gommers D; Lachmann B
    Monaldi Arch Chest Dis; 1995 Oct; 50(5):372-7. PubMed ID: 8541821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant and the adult respiratory distress syndrome.
    Lewis JF; Jobe AH
    Am Rev Respir Dis; 1993 Jan; 147(1):218-33. PubMed ID: 8420422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant inactivation and surfactant replacement in experimental models of ARDS.
    Robertson B
    Acta Anaesthesiol Scand Suppl; 1991; 95():22-8. PubMed ID: 1927224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant therapy.
    Lachmann B
    Resuscitation; 1989; 18 Suppl():S37-49. PubMed ID: 2555887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome.
    Lachmann B
    Eur Respir J Suppl; 1989 Mar; 3():98s-103s. PubMed ID: 2663002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of exogenous surfactant in the treatment of acute lung injury.
    Lewis JF; Veldhuizen R
    Annu Rev Physiol; 2003; 65():613-42. PubMed ID: 12517997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of surfactant therapy during ALI/ARDS.
    Lewis JF; Veldhuizen RA
    Semin Respir Crit Care Med; 2006 Aug; 27(4):377-88. PubMed ID: 16909371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome.
    Holm BA; Matalon S
    Anesth Analg; 1989 Dec; 69(6):805-18. PubMed ID: 2686493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials.
    Meng SS; Chang W; Lu ZH; Xie JF; Qiu HB; Yang Y; Guo FM
    BMC Pulm Med; 2019 Jan; 19(1):9. PubMed ID: 30626363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].
    Lauer S; Fischer LG; Stubbe HD; Van Aken H; Westphal M
    Anaesthesist; 2006 Apr; 55(4):433-42. PubMed ID: 16440205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute (Adult) respiratory distress syndrome. The holy grail of surfactant therapy.
    Taeusch HW
    Biol Neonate; 2000 May; 77 Suppl 1():2-8. PubMed ID: 10828579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.
    Seeger W; Günther A; Walmrath HD; Grimminger F; Lasch HG
    Clin Investig; 1993 Mar; 71(3):177-90. PubMed ID: 8481620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of exogenous surfactant in acute lung injury.
    Lewis JF; Brackenbury A
    Crit Care Med; 2003 Apr; 31(4 Suppl):S324-8. PubMed ID: 12682460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary surfactant composition early in development of acute lung injury after cardiopulmonary bypass: prophylactic use of surfactant therapy.
    Haslam PL; Baker CS; Hughes DA; MacNaughton PD; Moat NE; Dewar A; Aggarwal A; Evans TW
    Int J Exp Pathol; 1997 Aug; 78(4):277-89. PubMed ID: 9505939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
    Häfner D; Ibrahim M; Wollin L; Germann PG
    Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant supplementation in the lung.
    Anzueto A
    Respir Care Clin N Am; 2002 Jun; 8(2):211-36. PubMed ID: 12481816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surfactant replacement therapy increases life-span of patients with acute respiratory distress syndrome].
    Potapov AL; Novikov NIu; Tumanskiĭ VA; Babanin AA
    Klin Khir; 2013 Feb; (2):57-9. PubMed ID: 23705485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant treatment for congenital heart disease patients with acute respiratory distress syndrome.
    Alten JA; Borasino S; Pearce FB; Dabal RJ; Kirklin JK
    Congenit Heart Dis; 2010; 5(6):624-8. PubMed ID: 21106025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant in adult respiratory distress syndrome.
    Mason RJ
    Eur J Respir Dis Suppl; 1987; 153():229-36. PubMed ID: 3322863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.